Life Sciences
China IVD Market And Forecast To 2020
China In-Vitro Diagnostics (IVD) market is among the fastest growing in the world. It is anticipated that China IVD market will more than triple by 2020 from the 2014 level. With an aging population, a rapidly growing middle class and a government encouraging preventive care, China has the potential for more dramatic growth in the future.
Global Alzheimer’s Disease Drugs Market And Pipeline Drugs Market Analysis To 2020
With the ageing population, the number of patients suffering from Alzheimers disease is predicted to grow during the forecast period. Alzheimer`s treatment is a high risk, high reward market. Drugs currently available in the market have reached maturity; patent of leading drugs have expired. The current unmet needs represent a huge opportunity for pharmaceutical companies.
Global - Non-Invasive Prenatal Testing (NIPT) Market And Volume Analysis To 2020
The global market for NIPT is growing rapidly; it has been projected to grow at a double digit growth rate during the period 2015 - 2020. The competition in the NIPT market landscape is fierce and the companies are aggressively looking to push their test volume.
Global Prostate Cancer Therapeutics Market To 2020
The global market for prostate cancer therapeutics is increasing, driven primarily by the growth in the hormonal therapy markets. The main drivers for the prostate cancer market are the increase in the global aging population, innovation in drugs and developments in genomics and proteomics.
Global - Adult Vaccines Market And Company Analysis To 2020
The adult vaccines market has been forecasted to increase at a compound annual growth rate (CAGR) of around 7% over the next five years. The driving factors for adult vaccines growth are an increasing acceptance of adult vaccines and the public health focus on flu prevention, as well as introductions of new vaccines.
Global Proton Therapy Market And Centers Analysis
By 2018, the number of sites providing proton therapy in the US is expected to cross 25. Still, industry experts believe that players will miss out on a majority of cancer patients who can benefit with proton therapy, overlooking a huge multi Billion dollar potential market. In Unites States the numbers of patients treated with Proton Therapy is very low whereas; the potential candidates for proton therapy are in Millions.
Worldwide - Hepatitis C Drugs Market & Pipeline Drugs Analysis To 2019
The hepatitis C market is rapidly evolving as new launches prompt a significant paradigm shift in the treatment of the disease. In 2011, a breakthrough in HCV therapy was witnessed with the first two direct acting anti-HCV drugs (Incivek and Victrelis) came to market and were followed by the market approval of two additional anti-HCV drugs (Sovaldi and Olysio) in 2013.